Regenerative Outcomes

Biotechnology ResearchTennessee, United States2-10 Employees

Regenerative Outcomes is a Nashville-based biotechnology research firm that specializes in regulatory affairs and compliance consulting for small biotech companies and cellular therapy providers. Its services focus on navigating regulatory pathways to advance regenerative medicine products, with an emphasis on achieving RMAT designation and expediting potential market approval while allowing continued clinical development under an IND. The company serves clients in the regenerative medicine sector, helping them address regulatory challenges and accelerate drug development timelines. Based in Tennessee, Regenerative Outcomes originated from the Regenerative Outcomes Foundation, a non-profit established by founder Doug Oliver, a patient advocate involved in shaping the RMAT framework and related policy. The firm has publicly highlighted its role as a boutique provider within this niche regulatory space, differentiating itself through founder-led expertise and its context within the broader push to advance regenerative therapies. A notable recent development includes the launch of Clinical Trial Management services in 2021, expanding its outsourced regulatory and drug development support capabilities for small biotech clients conducting FDA-regulated trials.

Sign up for free to view info

Email Format Employee directory